Overview
Extracorporeal cardiopulmonary resuscitation, or ECPR, is an advanced form of resuscitation used when standard CPR is not enough to restore circulation. In ECPR, a specialized machine temporarily takes over the work of the heart and lungs by circulating and oxygenating the blood outside the body. This approach can buy time to treat the underlying cause of cardiac arrest, especially in patients whose arrest is thought to be reversible.
Although ECPR has been studied more extensively in adults, much less is known about its role in children who suffer out-of-hospital cardiac arrest, meaning a cardiac arrest that occurs before arrival at the hospital. Pediatric OHCA is rare, but when it happens, it is often catastrophic. Children may arrest because of heart disease, congenital abnormalities, respiratory failure, trauma, drowning, or other causes. Because children differ from adults in physiology, arrest causes, and response to treatment, adult ECPR data cannot simply be applied to pediatric care.
This study examined whether children and adolescents with OHCA who received ECPR had better outcomes than similar patients who continued conventional CPR.
Why this study matters
For children with cardiac arrest, every minute without effective circulation increases the risk of death and severe brain injury. Standard CPR can maintain some blood flow, but it is not always enough, especially when the arrest is prolonged or the cause is potentially reversible but requires time-sensitive treatment.
ECPR may be especially useful in carefully selected pediatric patients, such as those with witnessed arrest, a shockable or potentially cardiac cause, rapid transport to a hospital capable of extracorporeal life support, and a short no-flow or low-flow interval. However, ECPR is resource-intensive, requires an experienced team, and carries risks such as bleeding, vascular injury, clotting complications, and neurologic uncertainty. Determining whether it truly improves outcomes in children is therefore clinically important.
Study design
The investigators performed a retrospective cohort study using a multicenter Japanese out-of-hospital cardiac arrest registry covering 2014 to 2022. They included patients younger than 18 years who were transported to institutions capable of pediatric ECPR.
The key comparison was between patients who received ECPR and patients who remained at risk for ECPR but did not receive it. This is an important distinction. Rather than comparing all children with OHCA, the researchers focused on those who might realistically have been eligible for ECPR during the resuscitation period. This approach helps reduce bias when comparing a highly selected treatment group with a broader population.
To strengthen the comparison, the authors used risk-set matching with time-dependent propensity scores. In simple terms, this means they matched patients based on their likelihood of receiving ECPR at the time they were being considered for it, taking into account changing clinical information over time. Full matching allowed up to four control patients per ECPR case.
The primary outcome was survival at one month. The secondary outcome was favorable neurologic outcome, defined as Pediatric Cerebral Performance Category 1 to 3, which indicates good to moderate neurologic function rather than severe disability or coma.
Who was included
A total of 799 pediatric OHCA patients were identified in the registry, but only 27 received ECPR. After matching, 108 at-risk controls were included for comparison.
The children who received ECPR were mostly adolescents, with a median age of 14 years. Most arrests were witnessed, and the majority were of cardiogenic origin. These features suggest that the ECPR group represented a selected population in whom clinicians likely believed there was a meaningful chance of recovery if circulation could be restored quickly.
After matching, the characteristics of the ECPR and control groups were similar, which supports a more balanced comparison than would be possible with simple unadjusted analysis.
Main findings
The results suggested that ECPR may improve both survival and neurologic outcomes in selected pediatric OHCA patients.
At one month, survival was 25.9% in the ECPR group, compared with 11.1% in the control group. The risk ratio was 3.56, meaning the chance of surviving at one month was more than three times higher in the ECPR group. The reported risk difference was 17.3%, although the 95% confidence interval crossed zero, indicating statistical uncertainty around the exact size of benefit.
For favorable neurologic outcome, 18.5% of children in the ECPR group achieved Pediatric Cerebral Performance Category 1 to 3, compared with 6.5% in the control group. The risk ratio was 3.78, again suggesting a substantially higher likelihood of acceptable neurologic recovery among patients who received ECPR.
In practical terms, these findings indicate that ECPR may not only prolong life, but may also help preserve meaningful brain function in some children after OHCA. That said, the number of ECPR patients was small, so the estimates are imprecise.
How to interpret the confidence intervals
The confidence intervals were wide, which is common when a study includes relatively few treated patients. A wide confidence interval means the true benefit could be smaller or larger than the point estimate suggests. In this study, the confidence intervals for the risk differences included zero, highlighting uncertainty about the exact absolute improvement.
This does not mean the treatment is ineffective. Instead, it means the available data are not precise enough to definitively establish the magnitude of benefit. The risk ratios, however, did indicate a statistically significant association in favor of ECPR.
Clinical implications
These findings support the idea that pediatric ECPR may be beneficial in highly selected cases of OHCA, particularly when the arrest is witnessed, likely cardiac, and managed in a center with rapid extracorporeal support capability.
For emergency and critical care teams, the study reinforces several practical points:
First, patient selection matters. Not every child with OHCA is a candidate for ECPR. The potential benefit is highest when the cause may be reversible and when blood flow can be restored quickly enough to prevent irreversible brain injury.
Second, systems of care are crucial. ECPR requires a coordinated response involving prehospital providers, emergency physicians, pediatric intensivists, perfusion teams, and cardiothoracic expertise. Delays in deciding or initiating ECPR may reduce its effectiveness.
Third, neurologic outcome should be a core endpoint. Survival alone is not enough; the goal is survival with meaningful recovery. This study appropriately included both mortality and neurologic function.
Limitations
As with all observational studies, this research cannot prove that ECPR caused the better outcomes. There may still be residual confounding, meaning hidden differences between groups that were not fully captured in the registry. For example, clinicians may have selected ECPR for children who appeared more salvageable in ways that are hard to measure.
Other limitations include the small number of ECPR cases, which reduces statistical precision, and the fact that the study was conducted in Japan, where emergency systems, transport times, and hospital resources may differ from other countries. The findings may therefore not apply equally everywhere.
In addition, details such as exact timing of arrest, CPR quality, cannulation timing, and post-resuscitation care can strongly influence outcomes. These factors are difficult to fully standardize in real-world registry research.
What this means for future research
The study suggests enough promise to justify randomized trials or carefully designed prospective studies of pediatric ECPR. Such trials would ideally clarify which children benefit most, how fast ECPR must be started, and which prehospital or hospital systems can deliver it safely and effectively.
Future work should also examine cost, complications, quality of life, long-term neurologic recovery, and ethical considerations, since ECPR is a high-intensity intervention that should be reserved for situations where the potential benefit is realistic.
Bottom line
In this multicenter Japanese registry study, pediatric patients with out-of-hospital cardiac arrest who received ECPR appeared to have better one-month survival and better neurologic outcomes than similar patients who continued conventional CPR. The results are encouraging, but they are not definitive because the study was observational and the sample size was small.
For now, the evidence suggests that ECPR may be a valuable rescue strategy for carefully selected children and adolescents with OHCA in centers that can provide it rapidly and safely. The findings should help guide clinical planning and support the design of future randomized trials.
